Kings Arms Yard VCT

Kings Arms Yard VCT is a UK venture capital trust, not an operating biotech, pharma, or healthcare company. It invests in a diversified portfolio of higher-growth UK businesses, including some companies in healthcare, healthtech, software, and deep technology, with the goal of generating dividend income and long-term capital appreciation for shareholders. The trust is managed by Albion Capital and is publicly listed in London. In June 2024, Kings Arms Yard VCT PLC changed its name to Albion Crown VCT PLC while retaining the ticker KAY. Because it is an investment vehicle rather than a drug developer, it does not have a therapeutic pipeline, clinical stage assets, or proprietary modalities/targets in the usual biotech sense.